Clinical trials: Mild to Moderate COVID-19

Covid19

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

• Terminated
• Age: 65 years and older
• Phase 4
• Results posted

This is an open-label, pragmatic, single-dose study using matched controls in participants with mild to moderate COVID-19. Participants will track for developing symptoms while at home and upon reporting of symptoms will test for…

Trial name

UNITED (NCT04656691)

Testing

bamlanivimab

Where

United States

Volunteers

139 people, healthy volunteers welcome

Sponsor

Daniel Griffin